A Safety and Immunogenicity Trial of a Respiratory Syncytial Virus Vaccine, LYB005 in Healthy Adults

Clinical trial NCT06442241 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06442241
Sponsor: Guangzhou Patronus Biotech Co., Ltd.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Respiratory Syncytial Virus (RSV)RSV Infection

Start date: 2024-07-31
Primary completion: 2025-12-30
Enrollment: 84

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.